FdaApplication
ANDA 212423
Identifiers
- fda_app_no: ANDA212423
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2019-05-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | 2MG/5ML | SYRUP;ORAL |
1 product